| Advantages | They retain core disease characteristics, including genetic mutations and protein expression patterns, making them reliable tools for gastric cancer research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Stomach (Gastric) |
| Disease | Gastric Cancer, Malignant ascites |
| Organoid Characterization | Gastric cancer organoids exhibit strong pathological concordance with tumor tissues, expressing key markers including CK7, CEA, and LGR5. |
| Applications | By preserving tumor heterogeneity and modeling key elements of the tumor microenvironment (TME), they enable robust studies of disease progression and treatment response. As physiologically relevant systems, these organoids reflect the pathological and molecular hallmarks of gastric cancer and are essential for investigating disease mechanisms, evaluating drug efficacy, and advancing precision medicine approaches. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.